Neuroendocrine tumors of the stomach: Chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma

Gastric Cancer

Volumn 14, Issue 2, 2011, Pages 161-165

  Okita, Natsuko Tsuda ^a   Kato, Ken ^a   Takahari, Daisuke ^a   Hirashima, Yoshinori ^a   Nakajima, Takako E ^a   Matsubara, Junichi ^a   Hamaguchi, Tetsuya ^a   Yamada, Yasuhide ^a   Shimada, Yasuhiro ^a   Taniguchi, Hirokazu ^a   Shirao, Kuniaki ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Carcinoid tumor; Cisplatin; Irinotecan; Poorly differentiated neuroendocrine carcinoma; Stomach

Indexed keywords

CISPLATIN; IRINOTECAN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; DIARRHEA; DISTANT METASTASIS; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOCRINE TUMOR; ENDOSCOPIC MUCOSAL RESECTION; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NEUROENDOCRINE TUMOR; NEUROTOXICITY; POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; STOMACH CARCINOID; STOMACH TUMOR; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARCINOMA, NEUROENDOCRINE; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HISTORY, 17TH CENTURY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 79959375226     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0025-5     Document Type: Article

References (19)

1. JD Godwin 1975 Carcinoid tumors Cancer 36 560 569 1157019 10.1002/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4
2. Solcia E, Kloeppel G, Sobin LH. World Health Organization: International histological classification of tumours: histological typing of endocrine tumours. Berlin: Springer; 2000.
3. K Botch B Ahren H Ahlman S Falkmer G Granerus L Grimelius 2005 Gastric carcinoids. Biologic behavior and prognosis after differentiated treatment in relation to type Ann Surg 242 64 73 10.1097/01.sla.0000167862.52309.7d (Pubitemid 40917969)
4. B Brenner LH Tang DS Klimstra DP Kelsen 2004 Small-cell carcinomas of the gastrointestinal tract: a review J Clin Oncol 22 2730 2739 15226341 10.1200/JCO.2004.09.075 (Pubitemid 41103762)
5. CG Moertel LK Kvols MJ O'Connell J Rubin 1991 Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin Cancer 68 227 232 1712661 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I 1:STN:280:DyaK3MzgtVCjuw%3D%3D
6. E Mitry E Baudin M Ducreux JC Sabourin P Rufle T Aparicio, et al. 1999 Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin Br J Cancer 81 1351 1355 10604732 10.1038/sj.bjc.6690325 1:CAS:528:DC%2BD3cXls1KksA%3D%3D
7. JD Hainsworth DR Spigel S Litchy FA Greco 2006 Phase II trial of paclitaxel, carboplatin and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network study J Clin Oncol 24 3548 3554 16877720 10.1200/JCO.2005.05.0575 1:CAS:528: DC%2BD28XovVSjs7w%3D (Pubitemid 46630525)
8. K Noda Y Nishiwaki M Kawahara S Negoro T Sugiura A Yokoyama, et al. 2002 Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer N Engl J Med 346 85 91 11784874 10.1056/NEJMoa003034 1:CAS:528:DC%2BD38Xkt1OlsA%3D%3D (Pubitemid 34438898)
9. R Arnold 2005 Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options Best Pract Res Clin Gastroenterol 19 491 505 16183523 10.1016/j.bpg.2005.03.006 1:STN:280:DC%2BD2MrgvFCjsw%3D%3D (Pubitemid 41447714)
10. G Rindi O Luinetti M Cornaggia C Capella E Solcia 1993 Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study Gastroenterology 104 994 1006 7681798 1:STN:280:DyaK3s3hs1Smuw%3D%3D (Pubitemid 23090750)
11. G Rindi C Bordi S Rappel ST Rosa M Stolte E Solcia 1996 Gastric carcinoids and neuroendocrine carcinomas; pathogenesis, pathology and behavior World J Surg 20 168 172 8661813 10.1007/s002689900026 1:STN:280: DyaK28zisFKjtA%3D%3D (Pubitemid 26069482)
12. A Rinke HH Muller CS Brittinger KJ Klose P Barth M Wied, et al. 2009 Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group J Clin Oncol 27 4656 4663 19704057 10.1200/JCO.2009.22.8510 1:CAS:528:DC%2BD1MXhtlGgtbnJ
13. K Matsui M Kitagawa A Miwa Y Kuroda M Tsuji 1991 Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases Am J Gastroenterol 86 1167 1175 1715667 1:STN:280:DyaK3MzltlGjuw%3D%3D
14. K Arai M Matsuda 1998 Gastric small-cell carcinoma in Japan: a case report and review of the literature Am J Clin Oncol 21 458 461 9781599 10.1097/00000421-199810000-00007 1:STN:280:DyaK1cvlt1ymuw%3D%3D (Pubitemid 28480495)
15. S Sakuramoto M Sasako T Yamaguchi T Kinoshita M Fujii A Nashimoto, et al. 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810 1820 17978289 10.1056/NEJMoa072252 1:CAS:528:DC%2BD2sXht1Kit7bI (Pubitemid 350044801)
16. JP Pignon R Arriagata DC Ihde DH Johnson MC Perry RL Souhami, et al. 1992 A meta-analysis of thoracic radiotherapy for small-cell lung cancer N Engl J Med 327 1618 1624 1331787 10.1056/NEJM199212033272302 1:STN:280: DyaK3s%2FmtlSrtw%3D%3D
17. A Auperin R Arriagada JP Pignon C Le Péchoux A Gregor RJ Stephens, et al. 1999 Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission N Engl J Med 341 476 484 10441603 10.1056/NEJM199908123410703 1:STN:280:DyaK1MzltlGjsQ%3D%3D (Pubitemid 29372887)
18. MH Kulke B Wu D Ryan PC Enzinger AX Zhu JW Clark, et al. 2006 A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors Dig Dis Sci 51 1033 1038 16865563 10.1007/s10620-006-8001-3 1:CAS:528:DC%2BD28Xnt1yju7c%3D (Pubitemid 44127047)
19. N Boku A Ohtsu Y Shimada K Shirao Seki S H Saito, et al. 1999 Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer J Clin Oncol 17 319 323 10458249 1:CAS:528:DyaK1MXltVyrtg%3D%3D (Pubitemid 29022409)